Chronic orofacial pain animal models - progress and challenges
Autor: | Lucindo José Quintans-Júnior, Heitor G. Araújo-Filho, Erik Willyame Menezes Pereira, Jullyana S.S. Quintans, Adriana Rolim Campos |
---|---|
Rok vydání: | 2018 |
Předmět: |
Adult
0301 basic medicine Orofacial pain medicine.medical_specialty business.industry Chronic pain medicine.disease Animals Genetically Modified Disease Models Animal 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Facial Pain Drug Discovery medicine Physical therapy Animals Humans Chronic Pain medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Expert Opinion on Drug Discovery. 13:949-964 |
ISSN: | 1746-045X 1746-0441 |
DOI: | 10.1080/17460441.2018.1524458 |
Popis: | Chronic orofacial pain is one of the most common pain conditions experienced by adults. Animal models are often selected as the most useful scientific methodology to explore the pathophysiology of the disorders that cause this disabling pain to facilitate the development of new treatments. The creation of new models or the improvement of existing ones is essential for finding new ways to approach the complex neurobiology of this type of pain. Areas covered: The authors describe and discuss a variety of animal models used in chronic orofacial pain (COFP). Furthermore, they examine in detail the mechanisms of action involved in orofacial neuropathic pain and orofacial inflammatory pain. Expert opinion: The use of animal models has several advantages in chronic orofacial pain drug discovery. Choosing an animal model that most closely represents the human disease helps to increase the chances of finding effective new therapies and is key to the successful translation of preclinical research to clinical practice. Models using genetically modified animals seem promising but have not yet been fully developed for use in chronic orofacial pain research. Although animal models have provided significant advances in the pharmacological treatment of orofacial pain, several barriers still need to be overcome for better treatment options. |
Databáze: | OpenAIRE |
Externí odkaz: |